UroGen Pharma Ltd.
URGN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$127 | -$102 | -$110 | -$111 |
| Dep. & Amort. | $1 | $2 | $2 | $2 |
| Deferred Tax | $0 | $0 | $0 | $15 |
| Stock-Based Comp. | $13 | $9 | $11 | $23 |
| Change in WC | $5 | $3 | -$6 | -$13 |
| Other Non-Cash | $11 | $11 | $16 | -$1 |
| Operating Cash Flow | -$97 | -$76 | -$88 | -$85 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 | -$1 |
| Net Acquisitions | $0 | $0 | -$1 | -$5 |
| Inv. Purchases | -$128 | -$50 | -$63 | -$52 |
| Inv. Sales/Matur. | $108 | $49 | $64 | $57 |
| Other Inv. Act. | $0 | $0 | $1 | $5 |
| Investing Cash Flow | -$21 | -$1 | $1 | $4 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $24 | $0 | $96 | $0 |
| Stock Issued | $151 | $67 | $1 | -$0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $19 | $50 | $0 | $72 |
| Financing Cash Flow | $195 | $117 | $97 | $72 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $77 | $40 | $11 | -$9 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $96 | $56 | $46 | $54 |
| End Cash | $173 | $96 | $56 | $46 |
| Free Cash Flow | -$97 | -$77 | -$88 | -$86 |